ResearcherShanghai Jiao Tong UniversityNo recent work listed
Hao Qian
Matched on ORCID iD 0000-0001-5771-5865; OpenAlex author ID A5063778999. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2019: 4 papers · 2020: none · 2021: 2 papers · 2022: 1 paper
Papers 7
- Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer. First author DOI 10.3389/fimmu.2022.1089008↗
- Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.682261↗
- Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3389/fmolb.2021.676291↗
- Comparison of Radical Antegrade Modular Pancreatosplenectomy with Standard Retrograde Pancreatosplenectomy for Left-Sided Pancreatic Cancer: A Meta-Analysis an… Co-author DOI 10.12659/msm.914540↗
- TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy. Co-author DOI 10.21037/tcr.2019.09.50↗
- PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis. Co-author DOI 10.2147/ott.s206039↗
- INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT. Co-author DOI 10.2147/ott.s223221↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaxing Deng · 5 shared papers, 2019–2022 · strength 0.58
- Paper Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer. DOI 10.3389/fimmu.2022.1089008↗
- Paper Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to… DOI 10.3389/fcell.2021.682261↗
- Paper TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy. DOI 10.21037/tcr.2019.09.50↗
- Yuanchi Weng · 4 shared papers, 2019–2022 · strength 0.47
- Paper Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer. DOI 10.3389/fimmu.2022.1089008↗
- Paper TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy. DOI 10.21037/tcr.2019.09.50↗
- Paper PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an … DOI 10.2147/ott.s206039↗
- Xiaomei Tang · 4 shared papers, 2019–2021 · strength 0.40
- Paper Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to… DOI 10.3389/fcell.2021.682261↗
- Paper PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an … DOI 10.2147/ott.s206039↗
- Paper INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT. DOI 10.2147/ott.s223221↗
- Baiyong Shen · 4 shared papers, 2019–2021 · strength 0.40
- Paper Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to… DOI 10.3389/fcell.2021.682261↗
- Paper TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy. DOI 10.21037/tcr.2019.09.50↗
- Paper PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an … DOI 10.2147/ott.s206039↗
- Shuyu Zhai · 4 shared papers, 2019 · strength 0.38
- Paper TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy. DOI 10.21037/tcr.2019.09.50↗
- Paper PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an … DOI 10.2147/ott.s206039↗
- Paper INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT. DOI 10.2147/ott.s223221↗
- Shulin Zhao · 3 shared papers, 2019–2022 · strength 0.38
- Paper Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer. DOI 10.3389/fimmu.2022.1089008↗
- Paper TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy. DOI 10.21037/tcr.2019.09.50↗
- Paper Comparison of Radical Antegrade Modular Pancreatosplenectomy with Standard Retrograde Pancreatosplenectomy for Left-Sid… DOI 10.12659/msm.914540↗
- Zhen Huo · 3 shared papers, 2019 · strength 0.29
- Paper TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy. DOI 10.21037/tcr.2019.09.50↗
- Paper PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an … DOI 10.2147/ott.s206039↗
- Paper Comparison of Radical Antegrade Modular Pancreatosplenectomy with Standard Retrograde Pancreatosplenectomy for Left-Sid… DOI 10.12659/msm.914540↗
- Chenghong Peng · 2 shared papers, 2021 · strength 0.27
- Paper Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenoca… DOI 10.3389/fmolb.2021.676291↗
- Paper Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to… DOI 10.3389/fcell.2021.682261↗
- Xiongxiong Lu · 2 shared papers, 2019–2021 · strength 0.21
- Baiyong Shen · 1 shared paper, 2022 · strength 0.19
- Zengyu Feng · 1 shared paper, 2021 · strength 0.16
- Kexian Li · 1 shared paper, 2021 · strength 0.16
- Yulian Wu · 1 shared paper, 2021 · strength 0.16
- Weishen Wang · 1 shared paper, 2021 · strength 0.11
- Hongzhe Li · 1 shared paper, 2021 · strength 0.11
- Hao Chen · 1 shared paper, 2021 · strength 0.11
- Xi Cheng · 1 shared paper, 2019 · strength 0.10
- Yuanbin Liu · 1 shared paper, 2019 · strength 0.10
- Xiaxing Deng · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.